US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.
Drugs
Health
Pharma